Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02877550
Recruitment Status : Active, not recruiting
First Posted : August 24, 2016
Last Update Posted : December 1, 2020
Sponsor:
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : December 2021